Real-World Safety and Effectiveness of Infliximab in 255 Patients with Intestinal, Neurological, and Vascular Behçet's Disease: A Post-Marketing SurveillanceADVANCES IN THERAPYIF42024-10-162OAAI
Role of intrathecal production of IL-6 in the pathogenesis of chronic progressive neuro-Behcet's diseaseJOURNAL OF THE NEUROLOGICAL SCIENCESIF3.22024-08-012PRE
ENHANCED EXPRESSION OF MRNA FOR INTERFERON SIGNATURE GENES IN CD34+CELLS OF THE BONE MARROW IN RHEUMATOID ARTHRITIS在类风湿关节炎中,骨髓CD34+细胞中干扰素特征基因的mRNA表达增强。ANNALS OF THE RHEUMATIC DISEASESIF20.62024-06-010PRE
Histopathological characteristics of central nervous system in chronic progressive neuro-Behcet's diseaseJOURNAL OF THE NEUROLOGICAL SCIENCESIF3.22022-03-012PRE
Differential expression of antibodies to NMDA receptor in anti-NMDA receptor encephalitis and in neuropsychiatric systemic lupus erythematosusLUPUS SCIENCE & MEDICINEIF3.52019-11-138OAAI
Elevation of serum anti-glucose-regulated protein 78 antibodies in neuropsychiatric systemic lupus erythematosusLUPUS SCIENCE & MEDICINEIF3.52018-10-1016OAAI
Understanding the Antibody Repertoire in Neuropsychiatric Systemic Lupus Erythematosus and Neuromyelitis Optica Spectrum DisorderARTHRITIS & RHEUMATOLOGYIF10.92018-01-0951OAAI
Influences of timing of introduction of infliximab on the outcome of patients with chronic progressive neuro-Behcet's diseaseJOURNAL OF THE NEUROLOGICAL SCIENCESIF3.22017-10-010PREAI
Recommendations for the management of neuro-Behcet's disease by the Japanese national research committee for Behcet's diseaseJOURNAL OF THE NEUROLOGICAL SCIENCESIF3.22017-10-011PREAI
Distinct clinical features between acute and chronic progressive parenchymal neuro-Behcet disease: meta-analysisSCIENTIFIC REPORTSIF3.92017-08-3134OAAI
DIFFERENTIAL PATTERNS OF ATROPHY IN HIPPOCAMPUS AND BRAINSTEM BETWEEN CHRONIC PROGRESSIVE NEURO-BEHCET'S DISEASE AND ALZHEIMER'S DISEASEANNALS OF THE RHEUMATIC DISEASESIF20.62017-06-010OAAI
ROLE OF SERUM INTERLEUKIN-6 IN BLOOD BRAIN BARRIER DAMAGES IN NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUSANNALS OF THE RHEUMATIC DISEASESIF20.62017-06-011OAAI
RECOMMENDATIONS FOR THE MANAGEMENT OF NEURO-BEHET DISEASE BY JAPANESE RESEARCH COMMITTEE FOR BEHET DISEASEANNALS OF THE RHEUMATIC DISEASESIF20.62017-06-010OAAI
SERUM C5A IS INCREASED IN LUPUS NEPHRITIS AS WELL AS IN NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS THROUGH DIFFERENT MECHANISMSANNALS OF THE RHEUMATIC DISEASESIF20.62016-06-010PREAI
INFLIXIMAB THERAPY FOR NEURO-, VASCULAR, AND INTESTINAL BEHCET'S DISEASE: EFFICACY, SAFETY, AND PHARMACOKINETICS IN A MULTICENTER PROSPECTIVE STUDYANNALS OF THE RHEUMATIC DISEASESIF20.62016-06-010PREAI
BRAIN MRI IN PATIENTS WITH ACUTE CONFUSIONAL STATE OF DIFFUSE PSYCHIATRIC/NEUROPSYCHOLOGICAL SYNDROMES IN SYSTEMIC LUPUS ERYTHEMATOSUSANNALS OF THE RHEUMATIC DISEASESIF20.62016-06-010PREAI
Cognitive impairment in chronic progressive neuro-behcet's disease: comparative study of brainstem and hippocampus region using brain MRIJOURNAL OF THE NEUROLOGICAL SCIENCESIF3.22015-10-010PREAI
Long-term outcome of chronic progressive neurological manifestations in behcet's diseaseJOURNAL OF THE NEUROLOGICAL SCIENCESIF3.22015-10-010OAAI
CHARACTERISTIC CHANGES IN HISTOPATHOLOGY OF SYNOVIAL TISSUES FROM PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TOCILIZUMABANNALS OF THE RHEUMATIC DISEASESIF20.62015-06-010PREAI
Differential Characteristics of MPO-ANCA Positive and Negative Eosinophilic Granulomatosis with PolyangiitisJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22015-02-010OAAI